Epigenetic Noise Drives Maladaptive Transcription Factor Phase Separation, Underlying Cell-Type‑Specific Gene Regulatory Network Rewiring in Aging

Prof. Anya Ogawa (PhD)· Mar 23, 2026

Mechanism: Age-related NAD+ decline reduces SIRT1/6 activity, causing hyperacetylation and aberrant phase separation of TFs (FOXO3, Nrf2, PGC1α), which sequesters them from DNA, rewiring gene regulatory networks. Readout: Readout: NAD+ boosters or SIRT1 overexpression reduce TF acetylation and condensate formation, restoring healthy gene regulation and improving mitochondrial health.

Hypothesis

Age‑related epigenetic noise does not merely increase transcriptional stochasticity; it alters the biophysical properties of master regulator transcription factors (TFs) such that they undergo aberrant phase separation, sequestering them away from target DNA and rewiring gene regulatory networks (GRNs) in a cell‑type‑specific manner.

Mechanistic Model

Epigenetic noise alters TF post‑translational state – NAD⁺ decline reduces SIRT1/6 activity, leading to hyperacetylation of histone tails and, critically, of lysine‑rich low‑complexity domains in TFs like FOXO3, Nrf2, and PGC1α [1][2]. Acetylation increases the net negative charge and modifies interaction motifs that drive TF self‑assembly.
Shift in TF phase‑separation propensity – Hyperacetylated TFs exhibit altered intrinsic disorder, promoting the formation of non‑productive cytoplasmic or nucleoplasmic condensates that lack the co‑activator/repressor composition required for precise transcriptional control [3]. These condensates act as molecular sinks, reducing the effective nuclear concentration of TFs available for binding at enhancers and promoters.
Cell‑type‑specific vulnerability – Postmitotic cells (neurons, cardiomyocytes) have lower TF turnover and higher baseline expression of disordered TF isoforms, making them more prone to sequestration when epigenetic noise rises [4]. Stem cells, with robust TF synthesis and degradation cycles, tolerate the same noise level without significant condensate formation.
Feedback to epigenetic state – Sequestered TFs fail to recruit histone deacetylases and methyltransferases, perpetuating local acetylation and further eroding heterochromatin, thus closing a loop that amplifies epigenetic noise [5].

Testable Predictions

Prediction 1: In aged neurons, FOXO3, Nrf2, and PGC1α will show increased co‑localization with markers of cytoplasmic stress granules or nuclear speckles compared with young cells.
Prediction 2: Pharmacological elevation of NAD⁺ (e.g., NR supplementation) or SIRT1 overexpression will decrease TF hyperacetylation, reduce aberrant condensate formation, and restore target‑gene expression without altering overall TF protein levels.
Prediction 3: Artificial induction of TF phase separation (via fusions to prion‑like domains) in young cells will recapitulate the aged GRN rewiring profile, including downstream mitochondrial and inflammation signatures.
Prediction 4: Single‑cell ATAC‑seq coupled with TF‑condensate imaging will reveal that loss of TF binding at specific enhancers correlates with condensate occupancy, not merely with chromatin accessibility changes.

Experimental Approach

Live‑cell imaging – Generate knock‑in mouse lines expressing Halo‑tagged FOXO3, Nrf2, and PGC1α. Use confocal microscopy to quantify condensate number, size, and subcellular localization in hippocampal neurons and cardiomyocytes from young (3 mo) and aged (24 mo) mice.
Biochemical fractionation – Separate soluble, chromatin‑bound, and condensate fractions; assess TF acetylation status by Western blot with acetyl‑lysine antibodies.
Intervention – Treat aged mice with NAD⁺ booster (nicotinamide riboside) or deliver AAV‑SIRT1 for 8 weeks; repeat imaging and fractionation.
Multi‑omic readout – Perform single‑cell RNA‑seq and ATAC‑seq on the same cells to correlate condensate burden with gene expression changes and chromatin state.
Gain‑of‑function control – Express a FOXO3‑FUS low‑complexity domain fusion in young neurons; assess whether this induces aged‑like transcriptional signatures and mitochondrial dysfunction.

Potential Outcomes

If predictions hold: Demonstrates that epigenetic noise rewires GRNs via a biophysical mechanism (TF phase separation) that is reversible by restoring NAD⁺/SIRT1 activity, providing a unifying explanation for cell‑type‑specific aging and a concrete therapeutic target.
If predictions fail: Shows that TF sequestration does not correlate with epigenetic noise or GRN changes, steering focus toward alternative mechanisms such as altered TF‑cofactor stoichiometry or non‑condensate‑mediated DNA binding defects.

This hypothesis extends the current epigenetic‑noise framework by specifying a mechanistic conduit—maladaptive TF phase separation—that links molecular noise to tissue‑level functional decline and offers distinct, falsifiable experiments to validate or refute the model.

Hypothesis

Mechanistic Model

Epigenetic noise alters TF post‑translational state – NAD⁺ decline reduces SIRT1/6 activity, leading to hyperacetylation of histone tails and, critically, of lysine‑rich low‑complexity domains in TFs like FOXO3, Nrf2, and PGC1α [1][2]. Acetylation increases the net negative charge and modifies interaction motifs that drive TF self‑assembly.

Shift in TF phase‑separation propensity – Hyperacetylated TFs exhibit altered intrinsic disorder, promoting the formation of non‑productive cytoplasmic or nucleoplasmic condensates that lack the co‑activator/repressor composition required for precise transcriptional control [3]. These condensates act as molecular sinks, reducing the effective nuclear concentration of TFs available for binding at enhancers and promoters.

Cell‑type‑specific vulnerability – Postmitotic cells (neurons, cardiomyocytes) have lower TF turnover and higher baseline expression of disordered TF isoforms, making them more prone to sequestration when epigenetic noise rises [4]. Stem cells, with robust TF synthesis and degradation cycles, tolerate the same noise level without significant condensate formation.

Feedback to epigenetic state – Sequestered TFs fail to recruit histone deacetylases and methyltransferases, perpetuating local acetylation and further eroding heterochromatin, thus closing a loop that amplifies epigenetic noise [5].

Testable Predictions

Prediction 1: In aged neurons, FOXO3, Nrf2, and PGC1α will show increased co‑localization with markers of cytoplasmic stress granules or nuclear speckles compared with young cells.

Prediction 2: Pharmacological elevation of NAD⁺ (e.g., NR supplementation) or SIRT1 overexpression will decrease TF hyperacetylation, reduce aberrant condensate formation, and restore target‑gene expression without altering overall TF protein levels.

Prediction 3: Artificial induction of TF phase separation (via fusions to prion‑like domains) in young cells will recapitulate the aged GRN rewiring profile, including downstream mitochondrial and inflammation signatures.

Prediction 4: Single‑cell ATAC‑seq coupled with TF‑condensate imaging will reveal that loss of TF binding at specific enhancers correlates with condensate occupancy, not merely with chromatin accessibility changes.

Experimental Approach

Live‑cell imaging – Generate knock‑in mouse lines expressing Halo‑tagged FOXO3, Nrf2, and PGC1α. Use confocal microscopy to quantify condensate number, size, and subcellular localization in hippocampal neurons and cardiomyocytes from young (3 mo) and aged (24 mo) mice.

Biochemical fractionation – Separate soluble, chromatin‑bound, and condensate fractions; assess TF acetylation status by Western blot with acetyl‑lysine antibodies.

Intervention – Treat aged mice with NAD⁺ booster (nicotinamide riboside) or deliver AAV‑SIRT1 for 8 weeks; repeat imaging and fractionation.

Multi‑omic readout – Perform single‑cell RNA‑seq and ATAC‑seq on the same cells to correlate condensate burden with gene expression changes and chromatin state.

Gain‑of‑function control – Express a FOXO3‑FUS low‑complexity domain fusion in young neurons; assess whether this induces aged‑like transcriptional signatures and mitochondrial dysfunction.

Potential Outcomes

If predictions hold: Demonstrates that epigenetic noise rewires GRNs via a biophysical mechanism (TF phase separation) that is reversible by restoring NAD⁺/SIRT1 activity, providing a unifying explanation for cell‑type‑specific aging and a concrete therapeutic target.

If predictions fail: Shows that TF sequestration does not correlate with epigenetic noise or GRN changes, steering focus toward alternative mechanisms such as altered TF‑cofactor stoichiometry or non‑condensate‑mediated DNA binding defects.